Iridium's Next‑Generation Hybrid IoT Module and Development Kit are Now Commercially Available
The Iridium 9604 Module and Development Kit streamline global IoT development with integrated satellite, cellular, and GNSS connectivity MCLEAN, Va., June 23, 2026 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of...
ChinaAMC and KB Asset Management Sign Strategic MOU to Deepen Cross-Border Collaboration
SEOUL, South Korea, June 23, 2026 /PRNewswire/ -- China Asset Management Co., Ltd. (ChinaAMC) and KB Asset Management Co., Ltd. (KBAM) announced the signing of a strategic Memorandum of Understanding (MOU) in Seoul, marking a significant step in...
e-STORAGE and Axpo Partner on First Joint Battery Project in Italy
KITCHENER, ON, June 23, 2026 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, its energy storage solutions business, has entered into an agreement with Axpo subsidiary to deploy...
Empowering Agentic AI and Sustainable HPC: MiTAC Computing Showcases Agentic AI Infrastructure at ISC 2026
HAMBURG, Germany, June 23, 2026 /PRNewswire/ -- ISC 2026 – MiTAC Computing Technology Corp., a global leader in high-performance, energy-efficient server solutions and a subsidiary of MiTAC Holdings Corporation (TWSE:3706), is highlighting its...
Fair Play Menarini International Award
Diego Milito and Emilio Butragueño among the winners of the 30th edition FLORENCE, Italy, June 23, 2026 /PRNewswire/ -- The list of winners of the 30th Fair Play Menarini International Award, scheduled for July 2 in Florence, continues to include...
AutoFull Powers IEM Cologne Major 2026 with World-First Massage Gaming Chairs Featuring Cooling & Heating Seat
COLOGNE, Germany, June 23, 2026 /PRNewswire/ -- IEM Cologne Major 2026 concluded on June 21, with Team FALCONS claiming the championship after intense competition. As the Official Gaming Chair Partner of ESL Pro Tour 2026–2027, AutoFull provided...
Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
Phase I trial consists of two parts. Part A is a single ascending dose (SAD) study of ASC35 once-monthly Self-Assembling Lipid Depot (SALD) formulation; Part B is a head-to-head study of multiple ascending doses (MAD) of ASC35 once-monthly SALD...
New global estimates reveal 258 million children affected by crises as learning losses threaten an entire generation
Education Cannot Wait launches new report showing that educational needs are highly concentrated in the world's most severe crises: nearly 80% of all out-of-school crisis-affected children live in just 20 countries GENEVA, June 23, 2026 /PRNewswire/...